KRAS and lung carcinoma: To explore the role of YAP/TAZ in regulating the sensitivity of KRAS G12C–mutant cancer cells to KRAS G12C inhibitors, we knocked down YAP or TAZ separately in SW1573, a lung cancer cell line that is highly resistant to KRAS G12C inhibitors.